Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative pregabalin for postoperative pain after total knee replacement
ACTRN12623001360606Phase 4Recruiting
- Sponsor
- Bahrain Defence Force Hospital
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of pregabalin in postoperative pain (2 arms), sponsored by Bahrain Defence Force Hospital. Primary endpoint: Postoperative pain by Visual Analogue Score. Started Sep 2023; status: recruiting.
02
Drugs
pregabalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12623001360606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623001360606.